DermaVir Patch: Phase II data

In a double-blind, dose-ranging, German Phase II trial in 36 treatment-naïve HIV patients, 4 topical patches of DermaVir containing 0.1 mg DNA per patch administered every 6 weeks for 18 weeks signifi...